If your patient is uninsured or the prescribed medication is not covered, the takeda oncology patient assistance program (pap) may be able to provide eligible patients with a monthly supply of alunbrig® (brigatinib), fruzaqla® (fruquintinib), iclusig® (ponatinib), or ninlaro® (ixazomib) at no cost to them. If you have insurance and are looking for patient assistance or copay assistance for fruquintinib (fruzaqla®), we have provided links that may help. Takeda oncology here2assist® is a comprehensive support program committed to helping your patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their takeda oncology treatment
Works with your patients' insurance company to help get your patient started on their medication identifies available financial assistance that. Patient resources are available to help your patients and their caregivers we help patients continue their journey with fruzaqla by providing helpful educational resources. Hans takeda oncology here2assist® patient we’re here to help
Please see iclusig ® full prescribing information, including boxed warning. Works with your patients’ insurance company to help get your patient started on their medication identifies available financial assistance.
